Funder
National Institute of Health
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference13 articles.
1. Ellenberg S, Fleming T, DeMets D. Data monitoring committees in clinical trials: a practical perspective. 2nd ed. West Sussex: Wiley; 2019.
2. Herson J. Data and safety monitoring committees in clinical trials. 2nd ed. New York: Chapman and Hal; 2016.
3. Food and Drug Administration. Guidance for clinical trial sponsors: establishment and operation of clinical trial data monitoring committees; 2006. http://www.fda.gov/cber/gdlns/clindatmon.htm
4. European Medicines Agency, Committee for Medicinal Products for Human Use. Guideline on data monitoring committees. EMEA/CHMP/EWP/5872/03 Corr; 2005.
5. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; ICH Harmonsized Tripartite Guideline. Statistical principles for clinical trial E9. Current Step 4 version dated 5 February 1998 ICH
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献